Skip to content
akaturk Academic measurement
2025 SJR Q4 JCR Q4 · 0,2 2 matched articles ESCI

Journal detail

Acta Phlebologica

Publisher
Edizioni Minerva Medica
Country
Italy · Western Europe
Type
journal
ISSN
  • 1593232X
  • 18271766
Scopus 0,131 SJR
Scopus Q4 SJR Q
WoS Q4 JCR Q
WoS 0,2 JIF
Scopus 11 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,131
  • Quartile Q4
  • H-Index 11
  • Cites/doc 0,15
  • Docs (3y) 90
  • Cites (3y) 16

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,2
  • 5Y JIF 0,3
  • JCI 0,06

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q4

Areas

  • Medicine

WoS categories

  • Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q4 Q4 0,131 0,2 0,3 0,06 Q4 11
2024 Q4 Q4 0,133 0,3 0,3 0,07 Q4 10
2023 Q4 Q4 0,149 0,4 0,4 0,09 Q4 10
2022 Q4 — 0,186 0,3 0,3 0,08 Q4 10
2021 Q4 — 0,145 — — 0,06 Q4 10
2020 Q4 — 0,149 — — 0,05 Q4 10
2019 Q4 — 0,131 — — — — 10
2017 Q3 — 0,187 — — — — 10
2016 Q2 — 0,744 — — — — 10
2015 Q3 — 0,272 — — — — 10
2014 Q3 — 0,238 — — — — 10
2013 — — — — — — — 10

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE ESCI Q4 Q4 97/100
2024 PERIPHERAL VASCULAR DISEASE ESCI Q4 Q4 93/98
2023 PERIPHERAL VASCULAR DISEASE ESCI Q4 Q4 88/96
2022 PERIPHERAL VASCULAR DISEASE ESCI — Q4 —
2021 PERIPHERAL VASCULAR DISEASE ESCI — Q4 —
2020 PERIPHERAL VASCULAR DISEASE ESCI — Q4 —